The role of lovenox in preventing stroke in post-operative patients
To this day, many front line physicians do not know of the long-standing guidelines setting forth that some patients at risk for stroke who are chronically anticoagulated with coumadin should receive lovenox as a bridging therapy to prevent a recurrent thromboembolism. As such, many patients suffer devastating strokes as a result. Some of these people, unfortunately end up as plaintiffs in medical malpractice cases. Hopefully the stories of these unfortunate vicitms of malpractice will serve to educate the medical community on the importance of following published guidelines to prevent stroke.
Jeffrey S Mitchell
